NFKB1 and coronary artery disorder: In turn, Wang et al. have explored miR-92a as a potential biomarker for CAD in diabetes and a contributor to CAD onset through the activation of NF-κB, a critical regulator of inflammation, and its downstream inflammatory pathways [300].